Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention

Psychiatric diseases, such as schizophrenia, bipolar disorder, autism spectrum disorder, and major depressive disorder, place a huge health burden on society. Cognitive impairment is one of the core characteristics of psychiatric disorders and a vital determinant of social function and disease recur...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yafen, Meng, Weicheng, Liu, Zhixin, An, Qunxing, Hu, Xingbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666407/
https://www.ncbi.nlm.nih.gov/pubmed/36406755
http://dx.doi.org/10.3389/fncel.2022.1046692
_version_ 1784831499453857792
author Wang, Yafen
Meng, Weicheng
Liu, Zhixin
An, Qunxing
Hu, Xingbin
author_facet Wang, Yafen
Meng, Weicheng
Liu, Zhixin
An, Qunxing
Hu, Xingbin
author_sort Wang, Yafen
collection PubMed
description Psychiatric diseases, such as schizophrenia, bipolar disorder, autism spectrum disorder, and major depressive disorder, place a huge health burden on society. Cognitive impairment is one of the core characteristics of psychiatric disorders and a vital determinant of social function and disease recurrence in patients. This review thus aims to explore the underlying molecular mechanisms of cognitive impairment in major psychiatric disorders and identify valuable biomarkers for diagnosis, treatment and prevention of patients.
format Online
Article
Text
id pubmed-9666407
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96664072022-11-17 Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention Wang, Yafen Meng, Weicheng Liu, Zhixin An, Qunxing Hu, Xingbin Front Cell Neurosci Neuroscience Psychiatric diseases, such as schizophrenia, bipolar disorder, autism spectrum disorder, and major depressive disorder, place a huge health burden on society. Cognitive impairment is one of the core characteristics of psychiatric disorders and a vital determinant of social function and disease recurrence in patients. This review thus aims to explore the underlying molecular mechanisms of cognitive impairment in major psychiatric disorders and identify valuable biomarkers for diagnosis, treatment and prevention of patients. Frontiers Media S.A. 2022-11-02 /pmc/articles/PMC9666407/ /pubmed/36406755 http://dx.doi.org/10.3389/fncel.2022.1046692 Text en Copyright © 2022 Wang, Meng, Liu, An and Hu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Wang, Yafen
Meng, Weicheng
Liu, Zhixin
An, Qunxing
Hu, Xingbin
Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention
title Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention
title_full Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention
title_fullStr Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention
title_full_unstemmed Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention
title_short Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention
title_sort cognitive impairment in psychiatric diseases: biomarkers of diagnosis, treatment, and prevention
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666407/
https://www.ncbi.nlm.nih.gov/pubmed/36406755
http://dx.doi.org/10.3389/fncel.2022.1046692
work_keys_str_mv AT wangyafen cognitiveimpairmentinpsychiatricdiseasesbiomarkersofdiagnosistreatmentandprevention
AT mengweicheng cognitiveimpairmentinpsychiatricdiseasesbiomarkersofdiagnosistreatmentandprevention
AT liuzhixin cognitiveimpairmentinpsychiatricdiseasesbiomarkersofdiagnosistreatmentandprevention
AT anqunxing cognitiveimpairmentinpsychiatricdiseasesbiomarkersofdiagnosistreatmentandprevention
AT huxingbin cognitiveimpairmentinpsychiatricdiseasesbiomarkersofdiagnosistreatmentandprevention

Ejemplares similares